OrthoPediatrics Corp. (KIDS)
OrthoPediatrics Statistics
Share Statistics
OrthoPediatrics has 24.22M shares outstanding. The number of shares has increased by 2.83% in one year.
Shares Outstanding | 24.22M |
Shares Change (YoY) | 2.83% |
Shares Change (QoQ) | 0.01% |
Owned by Institutions (%) | 70.51% |
Shares Floating | 16.36M |
Failed to Deliver (FTD) Shares | 50 |
FTD / Avg. Volume | 0.02% |
Short Selling Information
The latest short interest is 914.87K, so 3.78% of the outstanding shares have been sold short.
Short Interest | 914.87K |
Short % of Shares Out | 3.78% |
Short % of Float | 5.6% |
Short Ratio (days to cover) | 2.97 |
Valuation Ratios
The PE ratio is -35.15 and the forward PE ratio is -31.71. OrthoPediatrics's PEG ratio is 0.02.
PE Ratio | -35.15 |
Forward PE | -31.71 |
PS Ratio | 4.96 |
Forward PS | 1.7 |
PB Ratio | 1.96 |
P/FCF Ratio | -16.02 |
PEG Ratio | 0.02 |
Enterprise Valuation
OrthoPediatrics Corp. has an Enterprise Value (EV) of 727.91M.
EV / Earnings | -34.71 |
EV / Sales | 4.89 |
EV / EBITDA | -86.85 |
EV / EBIT | -28.25 |
EV / FCF | -15.81 |
Financial Position
The company has a current ratio of 5.44, with a Debt / Equity ratio of 0.03.
Current Ratio | 5.44 |
Quick Ratio | 2.9 |
Debt / Equity | 0.03 |
Total Debt / Capitalization | 2.6 |
Cash Flow / Debt | -2.69 |
Interest Coverage | 0 |
Financial Efficiency
Return on equity (ROE) is -0.06% and return on capital (ROIC) is -6.55%.
Return on Equity (ROE) | -0.06% |
Return on Assets (ROA) | -0.05% |
Return on Capital (ROIC) | -6.55% |
Revenue Per Employee | $602,153.85 |
Profits Per Employee | $-84,914.98 |
Employee Count | 247 |
Asset Turnover | 0.34 |
Inventory Turnover | 0.35 |
Taxes
Income Tax | -338K |
Effective Tax Rate | 0.02 |
Stock Price Statistics
The stock price has increased by -16.26% in the last 52 weeks. The beta is 1.22, so OrthoPediatrics's price volatility has been higher than the market average.
Beta | 1.22 |
52-Week Price Change | -16.26% |
50-Day Moving Average | 24.2 |
200-Day Moving Average | 27.55 |
Relative Strength Index (RSI) | 40.4 |
Average Volume (20 Days) | 310.45K |
Income Statement
In the last 12 months, OrthoPediatrics had revenue of 148.73M and earned -20.97M in profits. Earnings per share was -0.92.
Revenue | 148.73M |
Gross Profit | 111.25M |
Operating Income | -25.77M |
Net Income | -20.97M |
EBITDA | -8.38M |
EBIT | -25.77M |
Earnings Per Share (EPS) | -0.92 |
Balance Sheet
The company has 31.05M in cash and 10.06M in debt, giving a net cash position of 21M.
Cash & Cash Equivalents | 31.05M |
Total Debt | 10.06M |
Net Cash | 21M |
Retained Earnings | -197.74M |
Total Assets | 489.29M |
Working Capital | 213.69M |
Cash Flow
In the last 12 months, operating cash flow was -27.05M and capital expenditures -18.98M, giving a free cash flow of -46.03M.
Operating Cash Flow | -27.05M |
Capital Expenditures | -18.98M |
Free Cash Flow | -46.03M |
FCF Per Share | -2.03 |
Margins
Gross margin is 74.8%, with operating and profit margins of -17.32% and -14.1%.
Gross Margin | 74.8% |
Operating Margin | -17.32% |
Pretax Margin | -14.33% |
Profit Margin | -14.1% |
EBITDA Margin | -5.63% |
EBIT Margin | -17.32% |
FCF Margin | -30.95% |
Dividends & Yields
KIDS does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Earnings Yield | -3.97% |
FCF Yield | -8.2% |
Analyst Forecast
The average price target for KIDS is $40, which is 72.6% higher than the current price. The consensus rating is "Buy".
Price Target | $40 |
Price Target Difference | 72.6% |
Analyst Consensus | Buy |
Analyst Count | 5 |
Scores
Altman Z-Score | 2.86 |
Piotroski F-Score | 2 |